India Remakes Global Innovation
Harvard Business Review
SEPTEMBER 14, 2011
Dr Reddy's plan is to leverage Chirotech's scientific capabilities to optimize drug development processes, thus lowering manufacturing costs and speeding time-to-market. You can't run your global R&D operations from headquarters in Mumbai. Decentralize and empower global R&D units. and the U.K. and the U.K.
9 
Let's personalize your content